Access all ESMO scientific and educational resources on this topic!
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Endocrine and Neuroendocrine Cancers
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Cabozantinib Shows ‘Potential’ For Radioiodine-Refractory Differentiated Thyroid Cancer
Neuroendocrine Tumour Treatments Reviewed
Gastroenteropancreatic NETs Show Late Recurrence Patterns
Dabrafenib–Trametinib Has ‘Robust Clinical Activity’ In BRAF-Mutated Anaplastic Thyroid Cancer
E-Learning
ESMO E-Learning: Overview on Management of Lung Neuroendocrine Tumours (Typical and Atypical Carcinoids)
ESMO E-Learning: Overview of the Diagnosis and Treatment of GI NETs
Meeting resources
2MO - XPO1 inhibition strongly sensitizes to first and second line therapy in small cell lung cancer
Presenter: alvaro Quintanal-Villalonga
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
Introducing a new scale for the routine assessment of sialadenitis in the radioiodine treatment context
Presenter: Andri Christou
Session: Health promotion, prevention and screening
Resources:
Slides
Webcast
Invited Discussant LBA41
Presenter: Angela Lamarca
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Slides
Webcast
Invited Discussant 1096O and 1097O
Presenter: Nicola Fazio
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Angela Lamarca
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Slides
Webcast